HLA Stock Overview
Healthia Limited provides health services in Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
Healthia Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$1.80 |
| 52 Week High | AU$1.80 |
| 52 Week Low | AU$0.85 |
| Beta | 1.08 |
| 11 Month Change | 0.84% |
| 3 Month Change | 3.01% |
| 1 Year Change | 52.12% |
| 33 Year Change | 39.15% |
| 5 Year Change | 74.27% |
| Change since IPO | 50.21% |
Recent News & Updates
Recent updates
Calculating The Fair Value Of Healthia Limited (ASX:HLA)
Jan 30
Healthia (ASX:HLA) Has Re-Affirmed Its Dividend Of AU$0.02
Mar 02Here's Why Healthia Limited's (ASX:HLA) CEO May Deserve A Raise
Nov 09Earnings Tell The Story For Healthia Limited (ASX:HLA) As Its Stock Soars 30%
Sep 17Healthia Limited (ASX:HLA) Stocks Shoot Up 30% But Its P/E Still Looks Reasonable
Sep 17Healthia (ASX:HLA) Is Increasing Its Dividend To AU$0.025
Sep 01I Ran A Stock Scan For Earnings Growth And Healthia (ASX:HLA) Passed With Ease
Aug 17Is Now An Opportune Moment To Examine Healthia Limited (ASX:HLA)?
May 19Is Healthia (ASX:HLA) A Risky Investment?
Apr 19With EPS Growth And More, Healthia (ASX:HLA) Is Interesting
Apr 03Announcing: Healthia (ASX:HLA) Stock Increased An Energizing 108% In The Last Year
Mar 19Insider Buying: The Healthia Limited (ASX:HLA) Independent Non-Executive Director Just Bought 4.7% More Shares
Mar 06What Kind Of Shareholders Hold The Majority In Healthia Limited's (ASX:HLA) Shares?
Feb 26Is There Now An Opportunity In Healthia Limited (ASX:HLA)?
Feb 09Healthia Limited's (ASX:HLA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 19Why Dividend Hunters Love Healthia Limited (ASX:HLA)
Dec 29Did You Miss Healthia's (ASX:HLA) 13% Share Price Gain?
Dec 10We're Not So Sure You Should Rely on Healthia's (ASX:HLA) Statutory Earnings
Nov 20
Shareholder Returns
| HLA | AU Healthcare | AU Market | |
|---|---|---|---|
| 7D | 0.3% | 5.7% | 0.9% |
| 1Y | 52.1% | 7.1% | 18.4% |
Return vs Industry: HLA exceeded the Australian Healthcare industry which returned -20.5% over the past year.
Return vs Market: HLA exceeded the Australian Market which returned 9.6% over the past year.
Price Volatility
| HLA volatility | |
|---|---|
| HLA Average Weekly Movement | 0.5% |
| Healthcare Industry Average Movement | 4.9% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in AU Market | 17.3% |
| 10% least volatile stocks in AU Market | 3.3% |
Stable Share Price: HLA's share price has been volatile over the past 3 months.
Volatility Over Time: HLA's weekly volatility has decreased from 12% to 0% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | n/a | Wes Coote | www.healthia.com.au |
Healthia Limited provides health services in Australia. It operates through three segments: Feet & Ankles; Bodies & Minds; and Eyes & Ears. The company operates podiatry and retail footwear; physiotherapy, hand therapy, occupational therapy, exercise physiology, and speech pathology clinics; and optometry and audiology stores, as well as manufactures and sells orthotic devices.
Healthia Limited Fundamentals Summary
| HLA fundamental statistics | |
|---|---|
| Market cap | AU$252.06m |
| Earnings (TTM) | AU$5.47m |
| Revenue (TTM) | AU$252.56m |
46.1x
P/E Ratio1.0x
P/S RatioIs HLA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HLA income statement (TTM) | |
|---|---|
| Revenue | AU$252.56m |
| Cost of Revenue | AU$175.80m |
| Gross Profit | AU$76.75m |
| Other Expenses | AU$71.29m |
| Earnings | AU$5.47m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.039 |
| Gross Margin | 30.39% |
| Net Profit Margin | 2.16% |
| Debt/Equity Ratio | 50.7% |
How did HLA perform over the long term?
See historical performance and comparison